Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study-Reference-Cited by-同舟云学术

Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study

Published:2021-06-23 Issue:11 Volume:116 Page:2250-2257
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Reig Anna,Álvarez-Navascués Carmen,Vergara Mercedes,Gómez-Domínguez Elena,Gallego-Moya Adolfo,Pérez-Medrano Indhira M.,Fábrega Emilio,Hernández-Guerra Manuel,Berenguer Marina,Estevez Pamela,Arencibia Ana,Morillas Rosa M.,Horta Diana,Albillos Agustín,Casado Marta,De la Cruz Gema,Fernandez-Bonilla Eva,Molina Esther,Hijona Lander,Diago Moises,Fernández-Rodriguez Conrado M.,González-Santiago Jesús M.,Sala Margarita,Gómez-Camarero Judith,Romero-Gomez Manuel,Suárez Francisco,Vargas Victor,Ferre-Aracil Carlos,Andrade Raúl J.,Chahri Nadia,Parés Albert

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference21 articles.

1. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid;Parés;Gastroenterology,2006

2. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid;Kuiper;Gastroenterology,2009

3. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis;Corpechot;Hepatology,2008

4. Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome;Corpechot;J Hepatol,2011

5. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis;Kumagi;Am J Gastroenterol,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort;Zeitschrift für Gastroenterologie;2024-09-03

2. Longitudinal outcomes of obeticholic acid therapy in ursodiol‐nonresponsive primary biliary cholangitis: Stratifying the impact of add‐on fibrates in real‐world practice;Alimentary Pharmacology & Therapeutics;2024-05

3. Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy;Hepatology;2024-03-06

4. Optimal drug regimens for improving ALP biochemical levels in patients with primary biliary cholangitis refractory to UDCA: a systematic review and Bayesian network meta-analysis;Systematic Reviews;2024-01-29

5. Letter to the Editor: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis;Hepatology;2023-12-27